1. Home
  2. RXRX vs AORT Comparison

RXRX vs AORT Comparison

Compare RXRX & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.50

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Artivion Inc.

AORT

Artivion Inc.

HOLD

Current Price

$28.17

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXRX
AORT
Founded
2013
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
RXRX
AORT
Price
$3.50
$28.17
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$7.50
$49.40
AVG Volume (30 Days)
15.5M
697.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
14.79
165.62
EPS
N/A
N/A
Revenue
$74,681,000.00
$298,836,000.00
Revenue This Year
$12.11
$14.20
Revenue Next Year
$82.52
$11.20
P/E Ratio
N/A
N/A
Revenue Growth
26.92
18.01
52 Week Low
$2.77
$19.16
52 Week High
$7.18
$48.25

Technical Indicators

Market Signals
Indicator
RXRX
AORT
Relative Strength Index (RSI) 58.90 57.96
Support Level $2.87 $25.79
Resistance Level $4.03 $38.02
Average True Range (ATR) 0.16 1.28
MACD 0.04 -0.04
Stochastic Oscillator 82.41 57.61

Price Performance

Historical Comparison
RXRX
AORT

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

About AORT Artivion Inc.

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

Share on Social Networks: